Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Intervention1: Individualized homoeopathic medicines in fifty millesimal potencies: Experimental arm(verum):Intervention is planned as administering indicated homoeopathic medicines
in 50 millesimal
The required doses will be determined as per requirement of individual cases. Potencies will be increased gradually depending upon the outcomes as per homoeopathic principles dosage will be adjusted a
Sponsors
The Calcutta Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Newly diagnosed cases of AD(ICD-11 CODE EA80.2)nas per Hanifin Rajka diagnostic criteria, 2.SCORAD values more than 10, 3.Patients of18-65 years of age and of either sex, 4.Literate patients;ability to read Bengali and /or English 5.Patients giving written consent to participate in the trial, 6.Patients already undergoing treatment for AD were planned to be recuited on completely stopping the medicines and after wash-out phase of 1 month
Exclusion criteria
Exclusion criteria: 1.Uncontrolled or life threatening illness,any organ failure and other comorbidities,vulnerable population-unconscious,ambulatory, 2.Patients who are too sick for consultation,differently abled,terminally ill or critically ill patients abuse and/or dependence 3.Pregnant and lactating women,puerperal mothers, psychiatric illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Scoring Atopic Dermatitis (SCORAD)Timepoint: At baseline,at every 4 weeks, upto 24weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatological life quality index(DLQI)Timepoint: At baseline,every 4 weeks,up to 24weeks | — |
Countries
India
Contacts
Public ContactSukanya Banerjee
Outcome results
None listed